Magnesium chloride composition for dermatological use
Provided herein is a topical composition and related methods for making and using the composition. In a first aspect, the topical composition comprises a magnesium salt (e.g. magnesium chloride) dissolved in an anhydrous or non-aqueous solvent. Exemplary solvents comprise a monohydric aliphatic alcohol, and a polyol.
1. A topical composition, comprising:
a magnesium salt dissolved in an anhydrous solvent comprised of a monohydric aliphatic alcohol and a polyol, wherein the composition does not comprise an active pharmaceutical ingredient other than the magnesium salt, wherein the monohydric aliphatic alcohol and polyol comprise 50-99.9% of the weight of the composition, and wherein the monohydric aliphatic alcohol and the polyol are in a ratio of from about 1:1 to 99:1.
2. The composition of claim 1 , wherein the monohydric aliphatic alcohol is present in the composition at a greater percent by weight than the polyol.
3. The composition of claim 1 , wherein the monohydric aliphatic alcohol to polyol ratio is between about 2:1 to 10:1.
4. The composition of claim 1 , wherein the monohydric aliphatic alcohol is selected from the group consisting of ethanol, isopropanol, propyl alcohol, tert-butyl alcohol, and combinations thereof.
5. The composition of claim 1 , wherein the monohydric aliphatic alcohol is a liquid at room temperature, the polyol is a liquid at room temperature, or both the monohydric aliphatic alcohol and the polyol are liquids at room temperature.
6. The composition of claim 1 , wherein the polyol is a C3-C8 diol or triol.
7. The composition of claim 1 , wherein the polyol is propylene glycol.
8. The composition of claim 1 , wherein the magnesium salt is selected from the group consisting of magnesium chloride, magnesium sulfate, magnesium salicylate, and combinations thereof.
9. The composition of claim 1 , wherein the magnesium salt is selected from the group consisting of the anhydrous magnesium chloride, anhydrous magnesium sulfate, anhydrous magnesium salicylate, and combinations thereof.
10. The composition of claim 1 , comprising between about 0.1% to about 10% by weight magnesium salt.
11. The composition of claim 10 , wherein the magnesium salt is magnesium chloride.
12. The composition of claim 1 , further comprising a thickening agent.
13. The composition of claim 12 , wherein the thickening agent is hydroxypropyl cellulose.
14. The composition of claim 1 , wherein the composition does not comprise an antibiotic.
15. A method for treating a dermatological condition or disease, comprising:
topically applying to an exterior epithelial surface of a human body a composition according to claim 1 at least once daily for a period of at least one week.
16. A method for treating acne or rosacea in a human subject, comprising topically applying to a local skin region affected by acne or rosacea a composition according to claim 1 at least once daily for a period of at least one week.
17. The method of claim 16 , wherein the acne or rosacea of the human subject is reduced from moderate or severe to clear or almost clear, according to the Investigator's Global Assessment (IGA), following 12 weeks of daily application of the composition.
18. The method of claim 16 , wherein an acne lesion count or rosacea lesion count for the human subject is reduced by more than 10 lesions following 12 weeks of daily application of the composition.
19. A method for manufacturing the composition of claim 1 , comprising: combining the magnesium salt, the monohydric aliphatic alcohol, and the polyol to form a mixture, and agitating the mixture to form a solution in which the magnesium salt is dissolved.